Clinical Trial Update: Epithelial Sodium Channel (ENaC) as a Novel Mechanism for Hypertension and Volume Expansion in Type 2 Diabetes [EARLY_Phase 1]

View source ↗

Summary

An early-phase (Phase 1) trial evaluating epithelial sodium channel (ENaC) as a novel mechanism for hypertension and volume expansion in type 2 diabetes was ter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Proteinuria
• Type 2 Diabetes Mellitus

Snippet

Sponsor: University of New Mexico | Conditions: Proteinuria, Hypertension | EARLY_Phase 1 | Status: TERMINATED